Navigation Links
Mayo Clinic's Dr. Denis Cortese Receives NCHL'S 2009 National Healthcare Leadership Award
Date:7/16/2009

NCHL, the leading authority on healthcare leadership, is pleased to honor Dr. Denis Cortese as the recipient of the 2009 National Healthcare Leadership Award for his lasting contributions to healthcare and his commitment to teamwork and mentorship during his 30-year career. Dr. Cortese is widely respected for his outspoken role in the national healthcare reform debate and for advocating for a system that ensures that all patients will receive outstanding and quality care.

CHICAGO, IL (PRWEB) July 16, 2009 -- The National Center for Healthcare Leadership (NCHL) said today it has named Denis A. Cortese, MD, president and chief executive officer of Mayo Clinic, as the recipient of the 2009 National Healthcare Leadership Award for his significant and lasting contributions to healthcare.

"Renowned for his commitment to teamwork and mentorship at one of the nation's premier healthcare organizations, Denis Cortese is also applying his leadership to impact the national healthcare agenda by building nationwide consensus for patient-centered change, advocating for a system that ensures that all patients will receive outstanding quality care," NCHL President and CEO Marie E. Sinioris said. "As an extraordinary leader and teacher, his innovative tenure at Mayo Clinic has included cutting edge programs in information technology and medical records, using new discoveries in genomics to customize patient-specific treatment strategies, and emphasis on bedside nursing to improve patient care. And under Dr. Cortese's leadership, Mayo Clinic launched the Health Policy Center, attracting thousands of patients and prominent thought leaders from across the nation to participate in a series of events to develop principles and action steps to guide healthcare reform."

Dr. Cortese will be honored on Wednesday, November 4, 2009 at an award event and recognition dinner at The Millennium Knickerbocker in Chicago that is being held in conjunction with NCHL's Invitational Symposium earlier that day. Dr. Cortese will be presented with an original glass sculpture by Czech-born artist Martin Rosol.

"The role for leadership in U.S. health care is wide open," Cortese said. "Leadership is less about 'you' or 'me' and more about us; what we can accomplish by working together. And much needs to be done to assure quality, affordable healthcare for all patients."

Thomas M. Priselac, president and CEO of Cedars-Sinai Health System and co-chair of the National Healthcare Leadership Award selection committee, praised Dr. Cortese's commitment to improving the nation's health. "During Dr. Cortese's career he has mirrored the vision of NCHL and used his unique ability to build consensus as he has advocated for a system of evidence-based, affordable, and accessible patient care for all," Priselac said. "The selection committee was honored to identify Dr. Cortese as this year's recipient and recognize his role as a forward thinking leader in national healthcare reform."

After serving as a Lieutenant Commander in the Medical Corps of the U.S. Navy, Cortese joined the Mayo Clinic staff in 1976 where he has been a professor of medicine and served as a former director of the Pulmonary Disease subspecialty training program. In 1993 he moved to Mayo Clinic in Jackson, Florida and in 2003 he was named CEO of Mayo Clinic in Rochester, Minnesota.

Dr. Cortese graduated from Temple University Medical School in 1970. He completed his internship and internal medicine residency at the Mayo Graduate School of Medicine. At Mayo Clinic he held a fellowship in thoracic diseases and was a special clinical fellow in bronchoscopy.

Widely published and the recipient of numerous honors and awards, Dr. Cortese is a member of The Institute of Medicine and chair of the Roundtable on Evidence-Based Medicine; Healthcare Leadership Council; Harvard/Kennedy Healthcare Policy Group; FRESH-Thinking; Advisory Board; World Community Grid; Academia Nacional de Medicine (Mexico); and the Royal College of Physicians (London).

Fawn Lopez, publisher of Modern Healthcare, which is co-sponsor of the NCHL National Healthcare Leadership Award, cited Dr. Cortese's many contributions to the field. "He has worked tirelessly and effectively to assert his leadership and influence to help frame the dialogue toward national healthcare reform. He sets a prime example for others to follow."

About National Center for Healthcare Leadership
The National Center for Healthcare Leadership (NCHL) is a not-for-profit organization that is an industry catalyst to assure the availability of accountable and transformational healthcare leadership for the 21st century. Its vision is to optimize the health of the public through leadership and organizational excellence. As the authoritative and objective source on healthcare leadership, NCHL conducts research on global best practices and tests new models for leadership excellence within its Leadership Excellence Networks (LENS). It provides innovative leadership development programs through the NCHL and GE Institute for Transformational Leadership.

# # #

Read the full story at http://www.prweb.com/releases/2009/07/prweb2639244.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Diplomat Specialty Pharmacy Expands National Growth Hormone Patient Care Program - Hires Denise Piro, RN, BSN
2. Medical Tactile, Inc. Announces Appointment of Denis A. OConnor as CEO & Member of Board of Directors
3. Size Does Matter ... and So Does Shape ... When It Comes to Teeth, Says Cosmetic Dentist, Dr. Denise Fundora
4. Todays Working Adults Face Long Term Care Double Whammy, Says Denise Gott, Spokesperson for LTC Financial Partners, LLC
5. PharmMD Announces Denise Kehoe as Vice President of Business Development
6. Komen for the Cure Central New Mexico Affiliate, Lt. Gov. Diane Denish, Sen. Dede Feldman, Breast Cancer Survivors Call on Elected Officials to Close the Gap in Access to Breast Health Services
7. Sysmex America Receives Highest Vendor Designation from MedAssets Supply Chain Systems
8. K-State scientist receives grant from National Institutes of Health to research cataracts
9. Wyeths Prevenar 13* Receives First Approval
10. Watson Pharmaceuticals Receives a Complete Response Letter for Its 24-Week Formulation of TRELSTAR(R) (triptorelin pamoate) NDA from US FDA
11. Bausch & Lomb Receives Approval of Crystalens HD in Quarter Diopter Steps
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Mayo Clinic's Dr. Denis Cortese Receives NCHL'S 2009 National Healthcare Leadership Award
(Date:12/11/2016)... PA (PRWEB) , ... December 11, 2016 , ... It’s ... nasal allergies that flare up. Tired of the sneezing, watery eyes and general discomfort ... solve this problem. , He then created a prototype of the patent-pending CLEAN AIR ...
(Date:12/10/2016)... ... December 09, 2016 , ... Even with breast cancer cited ... in recent years. This can be attributed to the improvement in breast cancer ... distributed. In response, Mediaplanet’s latest, cross-platform edition of “Breast Cancer Care” spotlights the ...
(Date:12/10/2016)... (PRWEB) , ... December 10, 2016 , ... ... presence in Harrisburg. PATS recently joined forces with other healthcare organizations to ... the State Capitol Rotunda in Harrisburg, featured a variety of speakers from around ...
(Date:12/9/2016)... MD (PRWEB) , ... December 09, 2016 , ... ... for counseling and aural rehabilitation—provided by audiologists—to remain a critical part of public ... Food and Drug Administration (FDA) announced this week that, starting immediately, ...
(Date:12/9/2016)... - Cincinnati, Ohio (PRWEB) , ... December 09, ... ... the production of miniature, folded, pharmaceutical inserts and outserts. As a means ... Device. This addition will enable Flottman to individually code professional inserts (PIs) ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)... DIEGO , Dec. 9, 2016  Forge ... Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: ... targeting ,LpxC, for the treatment of bacterial infections ... has been recognized as an attractive antibacterial target ... a lack of suitable chemical starting points has ...
(Date:12/8/2016)... 2016  The global biosurgery market is expected to ... period of 2016 to 2021. The market is poised ... 18.21 billion in 2016. The market is primarily driven ... related injuries and spinal problems, increasing clearance of biosurgery ... blood loss management. In this report, the ...
(Date:12/8/2016)... Allergy Diagnostics Market: Scope and Methodology ... are used to determine the presence of allergens ... etc. in the samples by determining the presence ... report on global allergy diagnostics market, analyzes the ... report consists of an executive summary that provides ...
Breaking Medicine Technology: